Zobrazeno 1 - 10
of 10
pro vyhledávání: '"M J Pierik"'
Publikováno v:
Journal of Crohn's and Colitis. 17:i945-i948
Background Reaching the STRIDE-II therapeutic targets for inflammatory bowel disease (IBD) requires an interdisciplinary approach. Lifestyle interventions focusing on enhancing and preserving health-related physical fitness (HRPF) may aid in improvin
Autor:
K Demers, A Rezazadeh Ardabili, B C Bongers, M J L Romberg-Camps, A A van Bodegraven, D M A E Jonkers, M J Pierik, L P S Stassen
Publikováno v:
Journal of Crohn's and Colitis. 17:i362-i364
Background Cardiorespiratory fitness (CRF) as a potential predictor of disease outcome in Inflammatory Bowel Disease (IBD) is understudied, as are risk factors for impaired CRF. Lifestyle interventions focusing on improving CRF may aid in enhancing s
Publikováno v:
Journal of Crohn's and Colitis.
Introduction The traditional long-term treatment goal of Crohn’s disease(CD) is maintenance of corticosteroid free clinical remission. Additional treatment targets, such as biochemical, endoscopic, and patient reported remission, are advocated. The
Autor:
A Rezazadeh Ardabili, L M Janssen, M J L Romberg-Camps, D Keszthelyi, D M A E Jonkers, A A van Bodegraven, M J Pierik, Z Mujagic
Publikováno v:
Journal of Crohn's and Colitis. 16:i056-i058
Background Chronic abdominal pain is highly prevalent in IBD patients in remission. The aetiology is incompletely understood, although persistent histologic inflammation, post-inflammatory visceral hypersensitivity, and altered gut-brain interaction
Autor:
G. M. C. Adriaans, R. J. Almeida, D. Jonkers, T. van den Heuvel, A. G. L. Bodelier, M. J. Pierik
Publikováno v:
2022 IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS (FUZZ-IEEE)
The incidence of inflammatory bowel disease (IBD) is rising worldwide. Preventing disease progression by tight monitoring of disease activity using non-invasive procedures is important to prevent disease progression. In literature composite scores, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e4f977a4744b69c7a69d5278fcfe3a
https://cris.maastrichtuniversity.nl/en/publications/22c8ab5d-d24d-48e4-9f39-b03403e79819
https://cris.maastrichtuniversity.nl/en/publications/22c8ab5d-d24d-48e4-9f39-b03403e79819
Autor:
G M C Adriaans, E M B Hendrix, R Creemers, L Janssen, K Demers, A Rezazadeh Ardabili, D M A E Jonkers, M J Pierik
Publikováno v:
Journal of Crohn's and Colitis. 16:i574-i575
Background The Real World Data [RWD] of the Dutch longitudinal IBD registries (population based IBD South Limburg cohort, Parelsnoer IBD, Initiative on Crohn and Colitis drug-registry) have proven to answer knowledge gaps regarding epidemiology, pati
Autor:
N Bevers MD, G M C Adriaans, A Aliu, A Rezazadeh Ardabili, A C E Vreugdenhil, R de Almeida, P F van Rheenen, M J Pierik
Publikováno v:
Journal of Crohn's and Colitis. 16:i215-i216
Background Anaemia is frequent in patients with IBD. Iron deficiency anaemia [IDA] and anaemia of chronic disease [ACD] are the most common subtypes and warrant a different treatment approach. The ESPGHAN/ NASHGAN position paper on Anaemia in Childre
Publikováno v:
Journal of Crohn's and Colitis. 16:i207-i208
Background Inflammatory bowel disease (IBD) is associated with malnutrition, which can further impair disease course and quality of life. Therefore, guidelines advocate screening of patients in clinical practice. The prevalence of malnutrition in IBD
Autor:
S F G, Jeuring, T R A, van den Heuvel, M P, Zeegers, J J, Haans, M J L, Romberg-Camps, L E, Oostenbrug, L P S, Stassen, A A M, Masclee, D M A E, Jonkers, M J, Pierik
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 161
To study changes in treatment and disease course in patients with Crohn's disease (CD) in the South Limburg region of the Netherlands between 1991 and 2014.Population-based cohort study.All 1162 CD patients in the 'IBD South Limburg cohort' were divi
Autor:
Z, Zelinkova, C, de Haar, L, de Ridder, M J, Pierik, E J, Kuipers, M P, Peppelenbosch, C J, van der Woude
Publikováno v:
Alimentary pharmacologytherapeutics. 33(9)
Typically, inflammatory bowel disease (IBD) patients are in their reproductive years, raising questions about safely using antitumour necrosis factor antibodies like infliximab (IFX) during pregnancy. IgG antibodies naturally cross the placenta, espe